Dr.
Fernando Martín Biscione
Unimed
Belo Horizonte Head of Epidemiology, Brazil
Email: fernandobiscione@gmail.com
Qualifications
2010 Ph.D., Minas Gerais Federal University, Brazil
2006 M.Sc., Minas Gerais Federal University, Brazil
Publications
(Selected)
-
Westin
MR, Biscione FM, Ribeiro KM, Greco DB, Tupinambas U. Effectiveness at 48 Weeks
of Switching from Enfuvirtide to Raltegravir in Virologically Suppressed
Multidrug-Resistant HIV Type 1-Infected Patients in a Brazilian
Cohort. AIDS Res Human Retroviruses 2013;30:113-117.
-
Ribeiro
KM, Biscione FM, Westin MR, Machado DP, Greco DB, Tupinambas U. Virologic and
immunologic effectiveness of darunavir-based salvage therapy in HIV-1-infected
adults in a Brazilian clinical practice setting: results of a multicenter and
retrospective cohort study. Braz J Infect Dis 2013;18:1-7.
-
Biscione
FM, Westin MR, Ribeiro KM, Estevam DL, Cardoso SW, Tenore SB, Neto LF,
Alencastro PR, Suffert TA, De Moraes MJ, Barbosa AN, Morejon KML, De Arruda
EAG, Silveira JM, Neto JLA, Greco DB, Tupinambas U. Virologic and Immunologic
Effectiveness at 48 Weeks of Darunavir-Ritonavir-Based Regimens in
Treatment-Experienced Persons Living with HIV-1 Infection in Clinical Practice:
A Multicenter Brazilian Cohort. J Int Assoc Provid AIDS Care 2013;13:63-68.
-
Biscione
FM, Couto RC, Pedrosa TM. Performance, Revision and Extension of the
National Nosocomial Infections Surveillance System's Risk Index in Brazilian
Hospitals. Infect Control Hosp Epidemiol 2012;33:124-134.
-
Souza
GF, Biscione FM, Greco DB, Rabello A. Slow clinical improvement after treatment
initiation in Leishmania/HIV coinfected patients. Rev Soc Bras Med Trop
2012;45:147-150.
-
Westin
MR, Biscione FM, Ordones M, Rodrigues M, Greco D, Tupinambas U.
Resistance-associated mutation prevalence according to subtypes B and non-B of
HIV-1 in antiretroviral-experienced patients in Minas Gerais, Brazil. AIDS Res
Human Retroviruses 2011;27:981-987.
-
Biscione
FM, Couto RC, Pedrosa TM. In the search of alternative cut-off points for the
variables of the National Nosocomial Infections Surveillance system’s surgical
site infection risk index. Biostatistics, Bioinformatics and Biomathematics
2011;2(2):67-81.
-
Biscione
FM, Couto RC, Pedrosa TM. Accounting for incomplete postdischarge follow-up
during surveillance of surgical site infection by use of the National
Nosocomial Infections Surveillance system’s risk index. Infect Control Hosp
Epidemiol 2009;30(5):433-439.
-
Biscione
FM. Rates of surgical site infection as a performance measure: are we ready?
World J Gastrointest Surg 2009;1(1):11-15.
-
Sales
ML, Penna AP, Xavier JA, Biscione FM, Paes de Sousa RP, do Bem Filho PM, de
Andrade Filho A, Lucas Jr. F. Description of a telemonitoring service for flu
syndrome cases during the first wave of the Influenza A (H1N1v) pandemic at
Unimed – Belo Horizonte (Brazil). Latin Am J Telehealth 2009;1(1):78-89.